Abstract
564P Co-occurring EGFR p.E709X mutation affects the treatment response to the third-generation EGFR-TKIs in EGFR p.G719X-mutant patients with advanced NSCLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have